Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$589K Buy
+4,582
New +$536K 0.1% 202
2025
Q4
Sell
-20,391
Closed -$1.71M 467
2025
Q3
$1.71M Buy
20,391
+6,685
+49% +$551K 0.32% 57
2025
Q2
$1.08M Buy
13,706
+1,945
+17% +$155K 0.19% 122
2025
Q1
$1.06M Buy
11,761
+2,973
+34% +$278K 0.2% 112
2024
Q4
$874K Buy
+8,788
New +$906K 0.18% 111

Other funds holding MRK

111 Capital's MRK Position: Q2 2026 in Review

111 Capital opened a new position in Merck (MRK) in Q2 2026: 4,582 shares worth $589K. The stake represents 0.1% of the portfolio and ranks #202 among its holdings. This is a return to the name: 111 Capital previously reported a position in MRK as recently as Q3 2025.

111 Capital first reported a position in MRK in Q4 2024 and has held it in 5 quarters since. The position peaked at $1.71M in Q3 2025. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • 111 Capital held 4,582 shares of Merck worth $589K as of Q2 2026.
  • Merck was a new 111 Capital position in Q2 2026.
  • Merck made up 0.1% of 111 Capital's portfolio in Q2 2026, its #202 holding.
  • 111 Capital first reported a position in Merck in Q4 2024 and has held it in 5 quarters since.
  • 111 Capital's Merck position peaked at $1.71M in Q3 2025.
  • 3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on 111 Capital's 13F filing for Q2 2026, filed 5 Aug 2026.